| Primary |
| Hypertension |
71.4% |
| Blood Cholesterol Increased |
3.6% |
| Diabetes Mellitus |
3.1% |
| Blood Pressure |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hypothyroidism |
2.0% |
| Prophylaxis |
1.9% |
| Cardiac Disorder |
1.5% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Anxiety |
1.3% |
| Insomnia |
1.2% |
| Hypersensitivity |
1.1% |
| Asthma |
1.0% |
| Pain |
1.0% |
| Blood Pressure Increased |
1.0% |
| Thyroid Disorder |
1.0% |
| Depression |
0.9% |
| Vitamin Supplementation |
0.8% |
| Hot Flush |
0.8% |
| Blood Pressure Management |
0.7% |
|
| Blood Pressure Increased |
15.3% |
| Drug Ineffective |
11.9% |
| Application Site Rash |
10.3% |
| Hypertension |
9.3% |
| Blood Pressure Inadequately Controlled |
8.9% |
| Application Site Pruritus |
7.0% |
| Headache |
4.2% |
| Rash |
4.1% |
| Application Site Vesicles |
3.7% |
| Application Site Irritation |
3.5% |
| Urticaria |
3.3% |
| Therapeutic Response Decreased |
2.8% |
| Somnolence |
2.6% |
| Application Site Erythema |
2.2% |
| Tremor |
2.0% |
| Hypotension |
1.9% |
| Rash Pruritic |
1.9% |
| Skin Irritation |
1.9% |
| Nausea |
1.7% |
| Blood Pressure Fluctuation |
1.6% |
|
| Secondary |
| Hypertension |
58.0% |
| Vitamin Supplementation |
4.4% |
| Blood Pressure |
4.1% |
| Blood Cholesterol Increased |
4.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Cardiac Disorder |
2.5% |
| Insomnia |
2.5% |
| Hypothyroidism |
2.4% |
| Constipation |
2.1% |
| Pain |
2.1% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.9% |
| Asthma |
1.7% |
| Sleep Disorder |
1.6% |
| Blood Pressure Fluctuation |
1.4% |
| Autonomic Nervous System Imbalance |
1.3% |
| Blood Pressure Management |
1.3% |
| Headache |
1.3% |
| Nasal Congestion |
1.3% |
| Prophylaxis |
1.3% |
|
| Hypertension |
12.7% |
| Blood Pressure Inadequately Controlled |
9.5% |
| Hypotension |
7.9% |
| Blood Pressure Increased |
7.1% |
| Drug Ineffective |
7.1% |
| Psychomotor Hyperactivity |
6.3% |
| Somnolence |
5.6% |
| Vomiting |
5.6% |
| Heart Rate Increased |
4.8% |
| Application Site Irritation |
3.2% |
| Blood Pressure Systolic Increased |
3.2% |
| Hypersensitivity |
3.2% |
| Rash |
3.2% |
| Skin Irritation |
3.2% |
| Sleep Disorder |
3.2% |
| Tremor |
3.2% |
| Viral Infection |
3.2% |
| Vision Blurred |
3.2% |
| Application Site Pruritus |
2.4% |
| Blood Pressure Fluctuation |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.0% |
| Drug Use For Unknown Indication |
16.1% |
| Hypertension |
13.4% |
| Pain |
4.8% |
| Multiple Myeloma |
4.5% |
| Blood Pressure |
3.0% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Blood Cholesterol Increased |
1.8% |
| Diabetes Mellitus |
1.8% |
| Asthma |
1.6% |
| Multiple Sclerosis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Arthritis |
1.4% |
| Blood Pressure Increased |
1.4% |
| Depression |
1.4% |
| Hypersensitivity |
1.4% |
| Angiogram |
1.3% |
| Anxiety |
1.3% |
| Dialysis |
1.3% |
| Convulsion |
1.2% |
|
| Wound Drainage |
12.2% |
| Pancreatitis Chronic |
8.9% |
| Weight Increased |
7.8% |
| Muscle Spasms |
5.6% |
| Pain |
5.6% |
| Somnolence |
5.6% |
| Vomiting |
5.6% |
| Weight Decreased |
5.6% |
| Renal Failure Chronic |
4.4% |
| Respiratory Failure |
4.4% |
| Swelling |
4.4% |
| Anaemia |
3.3% |
| Death |
3.3% |
| Drug Ineffective |
3.3% |
| Hypersensitivity |
3.3% |
| Pancreatic Carcinoma |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Hypertension |
3.3% |
| Renal Impairment |
3.3% |
| Stevens-johnson Syndrome |
3.3% |
|
